Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
NESR is heading into November earnings with a 32% monthly selloff, a deeply bullish analyst consensus, and a widening gap between what the Street expects and what peers are saying about Middle East activity.
The price tells the most urgent part of the story. NESR closed at $23.63 on Wednesday, down 7.2% on the week and 32% over the past month. That is a violent reversal from what had been a standout 2026 run. The stock was up more than 100% year-to-date as recently as late September, but the correction has now wiped out a substantial portion of those gains in just a few weeks. The next scheduled print is November 10, leaving roughly five weeks for the market to decide whether this is a sentiment-driven overreaction or a genuine reassessment of the MENA oilfield cycle.
The borrow market offers almost no corroboration for the selloff. Short interest is running at 4.8% of free float, effectively flat on the week after a brief mid-month spike toward 5.5%. Cost to borrow has fallen 23% over the week to 0.40%, well within the range it has occupied all year. Availability is extremely loose at 1,258%, compared to a 52-week low of 429%. There is no squeeze pressure here, and short sellers are not meaningfully building into the decline. The ORTEX short score has drifted down to 42.6 from 46 a week ago, moving in the opposite direction from the price. That divergence is worth noting: the selloff does not appear to be short-seller driven.
Options positioning adds another wrinkle. Demand for calls has dramatically outpaced puts, with the put/call ratio at 0.10, more than one standard deviation below its 20-day average of 0.22. That is the most call-heavy reading in at least a month, and stands well clear of the 52-week low of 0.00. Through early and mid-September the ratio ran above 0.38 for several weeks. The sharp rotation toward calls this week suggests at least some participants see the selloff as an opportunity rather than the start of a sustained decline.
The Street has trimmed but stayed firmly bullish. The consensus mean target is $42.11 against a $23.63 price, implying 78% upside on the analyst view. That gap is large enough to warrant a sanity check: it reflects a sharp and recent price decline rather than a stale data set. Piper Sandler cut its target modestly from $40 to $39 this week while keeping an Overweight rating. BMO Capital initiated coverage at Outperform with a $39 target this week. UBS trimmed from $47 to $46, also keeping Buy. The direction is slight trims rather than downgrades, and the bull case remains intact on paper: Q2 adjusted EBITDA beat the Street by roughly 16%, free cash flow ran near $100 million, and management has guided for at least $2 billion in FY26 revenue with a longer-term $3 billion target. The analyst recommendation divergence factor score is in the 96th percentile, meaning the consensus skew toward Buy is unusually strong relative to the broader universe. The stock trades at 5.1x EV/EBITDA and under 10x PE, both of which have compressed materially over the past 30 days as the price fell.
The bear case, however, has a concrete mechanism. Peers are describing a Middle East slowdown tied to rig suspensions, the East-West pipeline impact in Saudi Arabia, and storage and takeaway constraints that are pushing any regional recovery into 2027. NESR's MENA concentration, which is the core of the bull case, becomes a liability if Saudi and Iraqi activity pauses through year-end. On the week, closest peers NOV and WFRD fell 0.6% and 2.9% respectively. HP bucked the trend, adding 6.7%. The moves are mixed, but NESR's 7.2% weekly drop stands out relative to the group.
Institutional flows complicate the picture further. FMR added 1.7 million shares in the period to September 30. BlackRock added 1.2 million. Dimensional added 1 million. Geode added 888,000. That is a substantial accumulation from major passive and active managers into the period that captures much of the run-up. Whether those positions held through the October selloff is unknown. On the insider side, CEO Sherif Foda sold 100,000 shares on August 31 at $35.00, a $3.5 million open-market sale at prices well above current levels. Director Antonio Campo Mejia sold 63,324 shares on September 9 at $35.45. Neither trade was under a 10b5-1 plan. Net insider sales over the trailing 90 days total approximately $94.5 million in value. The sales happened at prices 48% to 50% above where the stock trades today.
One additional flag: Mubbadrah Investment LLC is on the Schedule 13D register, the activist filing type, last disclosing a 4.25% stake in February 2026, down from 5.1% previously. As-last-disclosed stakes around the 5% threshold can exit without further filing, so the current position is unknown. With the stock down 32% in a month, the next earnings release on November 10 is the clearest near-term test of whether the bear case around MENA activity is already in the price or has further to run.
See the live data behind this article on ORTEX.
Open NESR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
